Cancer Biomarkers

A cancer biomarker refers to a substance or process that's indicative of the presence of cancer within the body. A biomarker is also a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are often used for cancer diagnosing, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. A number of gene and protein based biomarkers have already been used at some point in patient care; including, AFP (Liver Cancer), BCR-ABL (Chronic Myeloid Leukemia), BRCA1 / BRCA2 (Breast/Ovarian Cancer), BRAF V600E (Melanoma/Colorectal Cancer)

Breast : ER/PR (estrogen receptor/progesteron receptor), HER-2/neu

Colorectal : EGFR , KRAS, UGT1A1

Gastric : HER-2/neu

GIST : c-KIT

 

  • Diagnostic
  • Prognostic, Predictive biomarkers

Related Conference of Cancer Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in